Alba Therapeutics in Washington Post | BeyondCeliac.org
X You may need to Reload the page to make it work correctly.

Alba Therapeutics in Washington Post

x

Celiac disease research needs you!

Opt-in to stay up-to-date on the latest news.

Yes, I want to advance research No, I'd prefer not to Don't show me this again

A new research study presented at the Digestive Disease Week meeting in San Diego found that a medicine called AT-1001 may protect celiac disease patients from exposure to gluten by preventing gluten from crossing the intestinal mucosa.

 

A new research study presented at the Digestive Disease Week meeting in San Diego found that a medicine called AT-1001 may protect celiac disease patients from exposure to gluten by preventing gluten from crossing the intestinal mucosa. In a second study at the meeting, researchers concluded that the current criteria for diagnosing celiac is too stringent, resulting in many patients going undiagnosed and untreated.www.washingtonpost.com/wp-dyn/content/article/2008/05/19/AR2008051901173.html

 

OUR SPONSORS & PARTNERS

Advertise with us

  • Gluten Detective
  • celiac disease research symposium
  • step beyond celiac virtual walk for celiac research
  • Look for the Beyond Celiac logo and shop gluten-free with confidence.
  • Gluten-Free Resource Directory


DO YOU THINK YOU MAY HAVE CELIAC DISEASE?

Complete our Celiac Disease Symptoms Checklist today to find out if you could have celiac disease and how to talk to your doctor about getting tested.